95 related articles for article (PubMed ID: 15182249)
21. Endosomal sorting of MHC class II determines antigen presentation by dendritic cells.
van Niel G; Wubbolts R; Stoorvogel W
Curr Opin Cell Biol; 2008 Aug; 20(4):437-44. PubMed ID: 18582577
[TBL] [Abstract][Full Text] [Related]
22. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.
Li P; Gregg JL; Wang N; Zhou D; O'Donnell P; Blum JS; Crotzer VL
Immunol Rev; 2005 Oct; 207():206-17. PubMed ID: 16181338
[TBL] [Abstract][Full Text] [Related]
23. Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces.
Villadangos JA; Schnorrer P; Wilson NS
Immunol Rev; 2005 Oct; 207():191-205. PubMed ID: 16181337
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
25. MHC class I antigen presentation--recently trimmed and well presented.
Flutter B; Gao B
Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
[TBL] [Abstract][Full Text] [Related]
26. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells.
Ackerman AL; Kyritsis C; Tampé R; Cresswell P
Nat Immunol; 2005 Jan; 6(1):107-13. PubMed ID: 15592474
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
[TBL] [Abstract][Full Text] [Related]
28. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
29. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
[TBL] [Abstract][Full Text] [Related]
30. Cross-presentation: underlying mechanisms and role in immune surveillance.
Rock KL; Shen L
Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
[TBL] [Abstract][Full Text] [Related]
31. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
[TBL] [Abstract][Full Text] [Related]
32. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins.
Tiwari N; Garbi N; Reinheckel T; Moldenhauer G; Hämmerling GJ; Momburg F
J Immunol; 2007 Jun; 178(12):7932-42. PubMed ID: 17548631
[TBL] [Abstract][Full Text] [Related]
33. Location of the epitope for an anti-CD8alpha antibody 53.6.7 which enhances CD8alpha-MHC class I interaction indicates antibody stabilization of a higher affinity CD8 conformation.
Devine L; Hodsdon ME; Daniels MA; Jameson SC; Kavathas PB
Immunol Lett; 2004 May; 93(2-3):123-30. PubMed ID: 15158607
[TBL] [Abstract][Full Text] [Related]
34. Macrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-gamma activation.
Martín-Orozco N; Isibasi A; Ortiz-Navarrete V
Immunology; 2001 May; 103(1):41-8. PubMed ID: 11380691
[TBL] [Abstract][Full Text] [Related]
35. IRAP identifies an endosomal compartment required for MHC class I cross-presentation.
Saveanu L; Carroll O; Weimershaus M; Guermonprez P; Firat E; Lindo V; Greer F; Davoust J; Kratzer R; Keller SR; Niedermann G; van Endert P
Science; 2009 Jul; 325(5937):213-7. PubMed ID: 19498108
[TBL] [Abstract][Full Text] [Related]
36. TLR9 activation increases TAP-independent vesicular MHC class I processing in vivo.
Chen L; Jondal M
Scand J Immunol; 2009 Nov; 70(5):431-8. PubMed ID: 19874547
[TBL] [Abstract][Full Text] [Related]
37. The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex.
Elliott T; Williams A
Immunol Rev; 2005 Oct; 207():89-99. PubMed ID: 16181329
[TBL] [Abstract][Full Text] [Related]
38. MHC class I-restricted exogenous presentation of a synthetic 102-mer malaria vaccine polypeptide.
Prato S; Maxwell T; Pinzón-Charry A; Schmidt CW; Corradin G; López JA
Eur J Immunol; 2005 Mar; 35(3):681-9. PubMed ID: 15688345
[TBL] [Abstract][Full Text] [Related]
39. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
Karlsson L
Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313
[TBL] [Abstract][Full Text] [Related]
40. Cytosolic aminopeptidases influence MHC class I-mediated antigen presentation in an allele-dependent manner.
Kim E; Kwak H; Ahn K
J Immunol; 2009 Dec; 183(11):7379-87. PubMed ID: 19917696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
